T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV‐infected children on anti‐retroviral therapy in Nairobi, Kenya

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 3, 2015-09 ,pp. : 451-456

John Wiley & Sons Inc

Access to resources Recommend Favorite

HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population

By Ormaasen Vidar   Sandvik Leiv   Dudman Susanne   Bruun Johan  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 1, 2007-01 ,pp. : 51-57

Informa Healthcare

Access to resources Recommend Favorite

Antiretroviral therapy in primary HIV infectio

By Powderly William G  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 3, 2013-05 ,pp. : 227-229

Future Medicine

Access to resources Recommend Favorite

Subcutaneous Interleukin-2 in Combination with Anti-retroviral Therapy for Treatment of HIV-1-Infected Subjects

By Larsen Carsten S.   Østergård Lars   Møller Bjarne K.   Buhl Mads R.  

Scandinavian Journal of Infectious Diseases, Vol. 32, Iss. 2, 2000-08 ,pp. : 153-160

Informa Healthcare

Access to resources Recommend Favorite

Highly active anti-retroviral therapy in the prevention of mother-to-child transmission of HIV in rural Zimbabwe during the socio-economic crisis

By Thistle Paul   Bolotin Shelly   Lam Eugene   Schwarz Dan   Pilon Richard   Ndawana Billy   Simor Andrew E.   Silverman Michael  

Medicine, Conflict and Survival, Vol. 27, Iss. 3, 2011-09 ,pp. : 165-176

Routledge Ltd

Access to resources Recommend Favorite